Skip to main content
Research project

Therapeutic targeting of a novel myeloid immune-checkpoint to overcome chemoresistance in breast cancer

Staff

Lead researcher

Dr Ali Roghanian PhD, FHEA

Associate Professor

Research interests

  • Cancer immunotherapy
  • Monoclonal antibodies
  • Immunoinhibitory receptors
Other researchers

Professor Stephen Beers

Professor of Immunology & Immunotherapy

Dr Matthew Rose-Zerilli BSc (Hons), PhD

Lecturer in Integrative Cancer Biology

Research interests

  • Cancer prevention
  • Innate immunity
  • Tumour microenvironment
Back
to top